HeraMED Limited (FRA:1I4)

Germany · Delayed Price · Currency is EUR

0.0180

0.00 (0.00%)

At close: Jun 24, 2026

350.00% (1Y)

Market Cap	26.63M +492.7%
Revenue (ttm)	245.20K -10.3%
Net Income	-2.35M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,000
Open	0.0180
Previous Close	n/a
Day's Range	0.0180 - 0.0180
52-Week Range	0.0035 - 0.0535
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Haw... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 2011

Country Australia

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 1I4

Financial Performance

In 2025, HeraMED's revenue was 431,605, a decrease of -10.31% compared to the previous year's 481,227. Losses were -4.13 million, -24.75% less than in 2024.

Financial numbers in AUD Financial Statements